Cabaletta Bio is trading at $3.27, up 5.05% now, with no clear company-specific catalyst confirmed for September 1, 2026.
- Cabaletta Bio announced upcoming investor conferences, but the release does not link them to today’s move.
- Broader markets and biotechnology stocks are weaker, making the rally difficult to attribute confidently to sector or global sentiment.